ProFunds.com
Home Open Account Access Account Professionals Contact
ProFunds.com
 

Ticker
Investor Class
PHPIX
Service Class
PHPSX

CUSIP
Investor Class
743185423
Service Class
743185415


Fund Number
Investor Class
047
Service Class
077


Inception Date
6/28/2000


View Proxy
Votes
Pharmaceuticals UltraSector ProFund

Vital Statistics

Class Ticker CUSIP Fund Number
Investor PHPIX 743185423 047
Service PHPSX 743185415 077

Inception Date for all share classes is 6/28/2000

NAV
as of 2/3/2012

Class NAV % Change $ Change
Investor $10.41 0.48% $0.05
Service $9.86 0.41% $0.04
Historical NAVs
Investor Class
Service Class ObjectiveThe Pharmaceuticals UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. PharmaceuticalsSM Index (the "Index") for a single day.
Dow Jones U.S. Pharmaceuticals Index
The Index (Bloomberg symbol: DJUSPR) measures the performance of the pharmaceuticals sector of the U.S. equity market. Component companies include, among others, the makers of prescription and over-the-counter drugs, such as birth control pills, vaccines, aspirin and cold remedies. It is not possible to invest directly in an index
Index (as of 12/31/2011)
Top 10 Index Companies
Name Weight
Johnson & Johnson 24.01%
Pfizer Inc. 22.24%
Merck & Co. Inc. 15.45%
Abbott Laboratories 11.68%
Bristol-Myers Squibb Co. 8.07%
Eli Lilly & Co. 5.43%
Allergan Inc. 3.61%
Mylan Inc. 1.24%
Pharmasset Inc. 1.18%
Perrigo Co. 1.12%
Total Index Companies
25
Average Index Market Capitalization
30.02 billion
Returns (as of 12/31/2011)
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. For standardized returns year-to-date and as of the most recent calendar quarter-end, see performance

Returns include the reinvestment of dividends and capital gains.

YTD (as of 2/3/2012) -1.14%
Average Annual One Year 24.68%
Average Annual Three Year 16.10%
Average Annual Five Year 1.74%
Average Annual Ten Year -3.58%
Average Annual Since Inception -4.70%
Cumulative Since Inception -42.55%
Gross Expense Ratio 2.44%
Net Expense Ratio 1.73%

Fund Statistics
Limits On Exchanges None
Minimum Investment
Individual Investor $15,000
Financial Professionals $5,000


All data, unless otherwise noted, is as of 12/31/2011 and for Investor Class Shares only and is subject to change.


Narrowly focused investments typically exhibit higher volatility.
 
 

Many ProFunds routinely employ leveraged investment techniques that magnify gains and losses, and result in greater volatility in value. Each geared (leveraged or inverse) ProFund seeks a return that is a multiple (e.g., 2x, -2x) of the return of an index or other benchmark (target) for a single day. Due to the compounding of daily returns, geared ProFunds' returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their ProFunds holdings consistent with their strategies, as frequently as daily. For more on risks, please read the prospectus.

ProFunds are not suitable for all investors because of the sophisticated techniques the funds employ. Investing involves risk, including the possible loss of principal. ProFunds entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. For more on correlation, leverage and other risks, please read the prospectus. There is no guarantee any ProFund will achieve its investment objective.

All ProFunds are subject to active investor risk. There are no restrictions on the size and frequency of trades and no transaction fees. The frequent exchanges our policies permit can decrease performance, increase expenses and cause investors to incur tax consequences.

Carefully consider the investment objectives, risks, charges and expenses of ProFunds before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

ProFunds are distributed by ProFunds Distributors, Inc.

Legal Information